FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Howard Thames

Research Profile

Concepts & Ideas

Living Beings

Disorders

Physiology

Procedures

Dose Fractionation

Chemicals & Drugs

Prostate Specific Antigen

Co-author Network

Publications

TOP 3
Nancy R Hunter; Zhongxing Liao; Luka Milas; Howard D Thames; David Valdecanas; Kathy A Mason
Mitigation and treatment of radiation-induced thoracic injury with a cyclooxygenase-2 inhibitor, celecoxib.
Susan L Tucker; Kathryn Winter; Walter R Bosch; James D Cox; Jeff M Michalski; Radhe Mohan; James A Purdy; Howard D Thames; Lei Dong
Estimation of α/β for late rectal toxicity based on RTOG 94-06.
Apostolos Menegakis; Howard D Thames; Ala Yaromina; Wolfgang Eicheler; Mechthild Krause; Michael Baumann
Residual DNA double strand breaks in perfused but not in unperfused areas determine different radiosensitivity of tumours.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Howard Thames (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Nancy R Hunter; Zhongxing Liao; Luka Milas; Howard D Thames; David Valdecanas; Kathy A Mason
Mitigation and treatment of radiation-induced thoracic injury with a cyclooxygenase-2 inhibitor, celecoxib.
International journal of radiation oncology, biology, physics 2013;85(2):472-6.
2011: Susan L Tucker; Kathryn Winter; Walter R Bosch; James D Cox; Jeff M Michalski; Radhe Mohan; James A Purdy; Howard D Thames; Lei Dong
Estimation of α/β for late rectal toxicity based on RTOG 94-06.
International journal of radiation oncology, biology, physics 2011;81(2):600-5.
2011: Apostolos Menegakis; Howard D Thames; Ala Yaromina; Wolfgang Eicheler; Mechthild Krause; Michael Baumann
Residual DNA double strand breaks in perfused but not in unperfused areas determine different radiosensitivity of tumours.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2011;100(1):137-44.
2010: Susan L Tucker; Lei Dong; Walter R Bosch; Jeff Michalski; Kathryn Winter; Radhe Mohan; James A Purdy; Deborah A Kuban; Andrew K Lee; Min Rex Cheung; Howard D Thames; James D Cox
Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model.
International journal of radiation oncology, biology, physics 2010;78(4):1253-60.
2010: Howard D Thames; Deborah A Kuban; Lawrence B Levy; Eric M Horwitz; Patrick A Kupelian; Alvaro Martinez; Jeffrey Michalski; Thomas M Pisansky; Howard Sandler; William Shipley; Michael J Zelefsky; Anthony L Zietman
The role of overall treatment time in the outcome of radiotherapy of prostate cancer: an analysis of biochemical failure in 4839 men treated between 1987 and 1995.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2010;96(1):6-12.
2010: David L Mitchell; André A Fernandez; Rodney S Nairn; Rachel Garcia; Lakshmi Paniker; David Trono; Howard D Thames; Irma B Gimenez-Conti
Ultraviolet A does not induce melanomas in a Xiphophorus hybrid fish model.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(20):9329-34.
2010: Jinyun Liu; K Leslie Powell; Howard D Thames; Michael C MacLeod
Detoxication of sulfur half-mustards by nucleophilic scavengers: robust activity of thiopurines.
Chemical research in toxicology 2010;23(3):488-96.
2010: Zhongxing X Liao; Ritsuko R Komaki; Howard D Thames; Helen H Liu; Susan L Tucker; Radhe Mohan; Mary K Martel; Xiong Wei; Kunyu Yang; Edward S Kim; George Blumenschein; Waun Ki Hong; James D Cox
Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy.
International journal of radiation oncology, biology, physics 2010;76(3):775-81.
2009: Apostolos Menegakis; Ala Yaromina; Wolfgang Eicheler; Annegret Dörfler; Bettina Beuthien-Baumann; Howard D Thames; Michael Baumann; Mechthild Krause
Prediction of clonogenic cell survival curves based on the number of residual DNA double strand breaks measured by gammaH2AX staining.
International journal of radiation biology 2009;85(11):1032-41.
2009: Mylin A Torres; Anuja Jhingran; Howard D Thames; Charles F Levenback; Diane C Bodurka; Lois M Ramondetta; Patricia J Eifel
Concurrent chemoradiation in the routine management of patients with cervical cancer: does marital status matter?
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2009;19(6):1107-12.
2008: Aijin Wang; Stacey Arantes; Leqin Yan; Kaoru Kiguchi; Mark J McArthur; Aysegul Sahin; Howard D Thames; C Marcelo Aldaz; Michael C MacLeod
The transcription factor ATF3 acts as an oncogene in mouse mammary tumorigenesis.
BMC cancer 2008;8():268.
2008: Mylin A Torres; Anuja Jhingran; Howard D Thames; Charles Levenback; Diane C Bodurka; Lois M Ramondetta; Patricia J Eifel
Comparison of treatment tolerance and outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with standard treatment.
International journal of radiation oncology, biology, physics 2008;70(1):118-25.
2007: Ala Yaromina; Mechthild Krause; Howard D Thames; Andrea Rosner; Mechthild Krause; Franziska Hessel; Reidar Grenman; Daniel Zips; Michael Baumann
Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2007;83(3):304-10.
2007: Pauline T Truong; Wendy A Woodward; Howard D Thames; Joseph Ragaz; Ivo A Olivotto; Thomas Buchholz
The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1-3 positive nodes: an analysis of prospective data from British Columbia and the M. D. Anderson Cancer Center.
International journal of radiation oncology, biology, physics 2007;68(1):59-65.
2007: Qi Wu; Kaoru Kiguchi; Toru Kawamoto; Tetsuo Ajiki; Jeanine Traag; Steve Carbajal; Lynnsie Ruffino; Howard D Thames; Ignacio Wistuba; Melanie Thomas; Karen M Vasquez; John DiGiovanni
Therapeutic effect of rapamycin on gallbladder cancer in a transgenic mouse model.
Cancer research 2007;67(8):3794-800.
2007: Min Rex Cheung; Susan L Tucker; Lei Dong; Renaud De Crevoisier; Andrew K Lee; Steven Frank; Rajat J Kudchadker; Howard D Thames; Radhe Mohan; Deborah A Kuban
Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer.
International journal of radiation oncology, biology, physics 2007;67(4):1059-65.
2007: Qi Wu; Sally Gaddis; Michael C MacLeod; Earl F Walborg; Howard D Thames; John DiGiovanni; Karen M Vasquez
High-affinity triplex-forming oligonucleotide target sequences in mammalian genomes.
Molecular carcinogenesis 2007;46(1):15-23.
2006: Ala Yaromina; Daniel Zips; Howard D Thames; Wolfgang Eicheler; Mechthild Krause; Andrea Rosner; Michael Haase; Cordula Petersen; James Raleigh; Verena Quennet; Stefan Walenta; Wolfgang Mueller-Klieser; Michael Baumann
Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studies.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2006;81(2):122-9.
2006: Eric M Horwitz; Lawrence B Levy; Howard D Thames; Patrick A Kupelian; Alvaro A Martinez; Jeff M Michalski; Thomas M Pisansky; Howard M Sandler; William U Shipley; Michael J Zelefsky; Anthony L Zietman; Deborah A Kuban
Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: a multiinstitutional pooled analysis.
Cancer 2006;107(7):1496-502.
2006: Mechthild Krause; Daniel Zips; Howard D Thames; Johann Kummermehr; Michael Baumann
Preclinical evaluation of molecular-targeted anticancer agents for radiotherapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2006;80(2):112-22.
2006: Julia L Oh; Mark D Bonnen; Elesyia D Outlaw; Naomi R Schechter; George H Perkins; Eric A Strom; Gildy V Babiera; Mary Jane Oswald; Pamela K Allen; Howard D Thames; Thomas Buchholz
The impact of young age on locoregional recurrence after doxorubicin-based breast conservation therapy in patients 40 years old or younger: How young is "young"?
International journal of radiation oncology, biology, physics 2006;65(5):1345-52.
2006: Mack Roach; Gerald Hanks; Howard D Thames; Paul Schellhammer; William U Shipley; Gerald H Sokol; Howard Sandler
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference.
International journal of radiation oncology, biology, physics 2006;65(4):965-74.
2006: Howard D Thames; Deborah A Kuban; Michelle DeSilvio; Lawrence B Levy; Eric M Horwitz; Patrick A Kupelian; Alvaro A Martinez; Jeff M Michalski; Thomas M Pisansky; Howard M Sandler; William U Shipley; Michael J Zelefsky; Anthony L Zietman
Increasing external beam dose for T1-T2 prostate cancer: effect on risk groups.
International journal of radiation oncology, biology, physics 2006;65(4):975-81.
2006: Susan L Tucker; Ming Zhang; Lei Dong; Radhe Mohan; Deborah A Kuban; Howard D Thames
Cluster model analysis of late rectal bleeding after IMRT of prostate cancer: a case-control study.
International journal of radiation oncology, biology, physics 2006;64(4):1255-64.
2006: Michael E Ray; Howard D Thames; Lawrence B Levy; Eric M Horwitz; Patrick A Kupelian; Alvaro A Martinez; Jeff M Michalski; Thomas M Pisansky; William U Shipley; Michael J Zelefsky; Anthony L Zietman; Deborah A Kuban
PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis.
International journal of radiation oncology, biology, physics 2006;64(4):1140-50.
2006: Sally Gaddis; Qi Wu; Howard D Thames; John DiGiovanni; Earl F Walborg; Michael C MacLeod; Karen M Vasquez
A web-based search engine for triplex-forming oligonucleotide target sequences.
Oligonucleotides 2006;16(2):196-201.
2005: Patrick A Kupelian; Howard D Thames; Larry Levy; Eric Horwitz; Alvaro Martinez; Jeff Michalski; Thomas M Pisansky; Howard Sandler; William U Shipley; Michael J Zelefsky; Anthony L Zietman; Deborah A Kuban
Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era.
International journal of radiation oncology, biology, physics 2005;63(3):795-9.
2005: Lea Spyres; Sally Gaddis; Ella Bedford; Stacey Arantes; Nikki Liburd; K Leslie Powell; Howard D Thames; David Mitchell; Earl F Walborg; Mahmoud Rouabhia; C Marcelo Aldaz; Michael C MacLeod
Quantitative high-throughput measurement of gene expression with sub-zeptomole sensitivity by capillary electrophoresis.
Analytical biochemistry 2005;345(2):284-95.
2005: Ala Yaromina; Tobias Hoelscher; Wolfgang Eicheler; Andrea Rosner; Mechthild Krause; Franziska Hessel; Cordula Petersen; Howard D Thames; Michael Baumann; Daniel Zips
Does heterogeneity of pimonidazole labelling correspond to the heterogeneity of radiation-response of FaDu human squamous cell carcinoma?
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2005;76(2):206-12.
2005: Mechthild Krause; Gernot Ostermann; Cordula Petersen; Ala Yaromina; Franziska Hessel; Andreas Harstrick; Albert J van der Kogel; Howard D Thames; Michael Baumann
Decreased repopulation as well as increased reoxygenation contribute to the improvement in local control after targeting of the EGFR by C225 during fractionated irradiation.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2005;76(2):162-7.
2005: Daniel Zips; Wolfgang Eicheler; Peter Geyer; Franziska Hessel; Annegret Dörfler; Howard D Thames; Martin Haberey; Michael Baumann
Enhanced susceptibility of irradiated tumor vessels to vascular endothelial growth factor receptor tyrosine kinase inhibition.
Cancer research 2005;65(12):5374-9.
2005: Deborah A Kuban; Howard D Thames; William U Shipley
Defining recurrence after radiation for prostate cancer.
The Journal of urology 2005;173(6):1871-8.
2005: Cordula Petersen; Daniel Zips; Mechthild Krause; Wolfram Völkel; Howard D Thames; Michael Baumann
Recovery from sublethal damage during fractionated irradiation of human FaDu SCC.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2005;74(3):331-6.
2005: Eric M Horwitz; Howard D Thames; Deborah A Kuban; Lawrence B Levy; Patrick A Kupelian; Alvaro A Martinez; Jeff M Michalski; Thomas M Pisansky; Howard M Sandler; William U Shipley; Michael J Zelefsky; Gerald E Hanks; Anthony L Zietman
Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled analysis.
The Journal of urology 2005;173(3):797-802.
2005: Daniel Zips; Franziska Hessel; Mechthild Krause; Yvonne Schiefer; Cordelia Hoinkis; Howard D Thames; Martin Haberey; Michael Baumann
Impact of adjuvant inhibition of vascular endothelial growth factor receptor tyrosine kinases on tumor growth delay and local tumor control after fractionated irradiation in human squamous cell carcinomas in nude mice.
International journal of radiation oncology, biology, physics 2005;61(3):908-14.
2005: Allen M Chen; Funda Meric-Bernstam; Kelly K Hunt; Howard D Thames; Elesyia D Outlaw; Eric A Strom; Marsha D McNeese; Henry M Kuerer; Merrick I Ross; S Eva Singletary; Frederick C Ames; Barry W Feig; Aysegul A Sahin; George H Perkins; Gildy V Babiera; Gabriel N Hortobagyi; Thomas Buchholz
Breast conservation after neoadjuvant chemotherapy.
Cancer 2005;103(4):689-95.
2005: Patrick A Kupelian; Deborah A Kuban; Howard D Thames; Larry Levy; Eric Horwitz; Alvaro Martinez; Jeff Michalski; Thomas M Pisansky; Howard Sandler; William U Shipley; Michael J Zelefsky; Anthony L Zietman
Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995.
International journal of radiation oncology, biology, physics 2005;61(2):415-9.
2005: Deborah A Kuban; Howard D Thames; Larry Levy; Eric Horwitz; Patrick A Kupelian; Alvaro Martinez; Jeff Michalski; Thomas M Pisansky; Howard Sandler; William U Shipley; Michael J Zelefsky; Anthony L Zietman
Failure definition-dependent differences in outcome following radiation for localized prostate cancer: can one size fit all?
International journal of radiation oncology, biology, physics 2005;61(2):409-14.
2005: Daniel Zips; Howard D Thames; Michael Baumann
New anticancer agents: in vitro and in vivo evaluation.
In vivo (Athens, Greece) 2005;19(1):1-7.
2004: Susan L Tucker; Lei Dong; Rex Cheung; Jennifer Johnson; Radhe Mohan; Eugene H Huang; H Helen Liu; Howard D Thames; Deborah A Kuban
Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy.
International journal of radiation oncology, biology, physics 2004;60(5):1589-601.
2004: Tse-Kuan Yu; Gary J Whitman; Howard D Thames; Aman U Buzdar; Eric A Strom; George H Perkins; Naomi R Schechter; Marsha D McNeese; Shu-Wan Kau; Eva S Thomas; Gabriel N Hortobagyi; Thomas Buchholz
Clinically relevant pneumonitis after sequential paclitaxel-based chemotherapy and radiotherapy in breast cancer patients.
Journal of the National Cancer Institute 2004;96(22):1676-81.
2004: Franziska Hessel; Mechthild Krause; A Helm; Cordula Petersen; Reidar Grenman; Howard D Thames; Michael Baumann
Differentiation status of human squamous cell carcinoma xenografts does not appear to correlate with the repopulation capacity of clonogenic tumour cells during fractionated irradiation.
International journal of radiation biology 2004;80(10):719-27.
2004: Radhika Iyer; Howard D Thames; Ja Rhonda Tealer; Kathryn A Mason; Susan C Evans
Effect of reduced EGFR function on the radiosensitivity and proliferative capacity of mouse jejunal crypt clonogens.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2004;72(3):283-9.
2004: Howard D Thames; Ming Zhang; Susan L Tucker; H Helen Liu; Lei Dong; Radhe Mohan
Cluster models of dose-volume effects.
International journal of radiation oncology, biology, physics 2004;59(5):1491-504.
2004: Karen H Shahar; Kelly K Hunt; Howard D Thames; Merrick I Ross; George H Perkins; Henry M Kuerer; Eric A Strom; Marsha D McNeese; Funda Meric; Naomi R Schechter; Aysegul A Sahin; Lavinia P Middleton; Thomas Buchholz
Factors predictive of having four or more positive axillary lymph nodes in patients with positive sentinel lymph nodes: implications for selection of radiation fields.
International journal of radiation oncology, biology, physics 2004;59(4):1074-9.
2004: Allen M Chen; Funda Meric-Bernstam; Kelly K Hunt; Howard D Thames; Mary Jane Oswald; Elesyia D Outlaw; Eric A Strom; Marsha D McNeese; Henry M Kuerer; Merrick I Ross; S Eva Singletary; Frederick C Ames; Barry W Feig; Aysegul A Sahin; George H Perkins; Naomi R Schechter; Gabriel N Hortobagyi; Thomas Buchholz
Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(12):2303-12.
2004: Susan L Tucker; Rex Cheung; Lei Dong; H Helen Liu; Howard D Thames; Eugene H Huang; Deborah A Kuban; Radhe Mohan
Dose-volume response analyses of late rectal bleeding after radiotherapy for prostate cancer.
International journal of radiation oncology, biology, physics 2004;59(2):353-65.
2004: Deborah A Kuban; Howard D Thames; Lawrence B Levy
PSA after radiation for prostate cancer.
Oncology (Williston Park, N.Y.) 2004;18(5):595-604; discussion 605, 609.
2004: Warren D D'Souza; Howard D Thames; Deborah A Kuban
Dose-volume conundrum for response of prostate cancer to brachytherapy: summary dosimetric measures and their relationship to tumor control probability.
International journal of radiation oncology, biology, physics 2004;58(5):1540-8.
2004: Sheikh M Ismail; Monica Puppi; Sheela Prithivirajsingh; Anupama Munshi; Uma Raju; Raymond E Meyn; Thomas Buchholz; Michael D Story; William A Brock; Luka Milas; Howard D Thames; Craig W Stevens
Predicting radiosensitivity using DNA end-binding complex analysis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(4):1226-34.
2004: Franziska Hessel; Mechthild Krause; Cordula Petersen; M Hörcsöki; T Klinger; Daniel Zips; Howard D Thames; Michael Baumann
Repopulation of moderately well-differentiated and keratinizing GL human squamous cell carcinomas growing in nude mice.
International journal of radiation oncology, biology, physics 2004;58(2):510-8.
2003: Howard D Thames; Deborah A Kuban; Larry Levy; Eric M Horwitz; Patrick A Kupelian; Alvaro Martinez; Jeff Michalski; Thomas M Pisansky; Howard Sandler; William U Shipley; Michael J Zelefsky; Anthony L Zietman
Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995.
International journal of radiation oncology, biology, physics 2003;57(4):929-43.
2003: Deborah A Kuban; Howard D Thames; Lawrence B Levy; Eric M Horwitz; Patrick A Kupelian; Alvaro A Martinez; Jeff M Michalski; Thomas M Pisansky; Howard M Sandler; William U Shipley; Michael J Zelefsky; Anthony L Zietman
Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era.
International journal of radiation oncology, biology, physics 2003;57(4):915-28.
2003: Christopher H Crane; Howard D Thames; Stanley R Hamilton
Will identifying or targeting altered marker expression in response to cytotoxic therapy be of prognostic or therapeutic value?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(18):3381-2.
2003: Deborah A Kuban; Howard D Thames; Lawrence B Levy
Radiation for prostate cancer: use of biochemical failure as an endpoint following radiotherapy.
World journal of urology 2003;21(4):253-64.
2003: Mechthild Krause; Michael Baumann; Howard D Thames
In regard to Solomon et al.: EGFR blockade with ZD1839 ("Iressa") potentiates the antitumor effects of single and multiple fractions of ionizing radiation in human A431 squamous cell carcinoma. IJROBP 2003;55:713-723.
International journal of radiation oncology, biology, physics 2003;57(1):300-1; author reply 301.
2003: Christopher H Crane; John M Skibber; Elisa H Birnbaum; Barry W Feig; anurag singh; Marc E Delclos; Edward H Lin; James W Fleshman; Howard D Thames; Ira J Kodner; Mary Ann Lockett; Joel Picus; Thinh Phan; Anshu Chandra; Nora Janjan; Thomas E Read; Robert J Myerson
The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer.
International journal of radiation oncology, biology, physics 2003;57(1):84-9.
2003: Howard D Thames; Warren D D'Souza; Deborah A Kuban
Dual radiobiological interpretations of retrospective clinical data: the time factor.
International journal of radiation biology 2003;79(7):503-9.
2003: Franziska Hessel; Cordula Petersen; Daniel Zips; Mechthild Krause; D Pfitzmann; Howard D Thames; Michael Baumann
Impact of increased cell loss on the repopulation rate during fractionated irradiation in human FaDu squamous cell carcinoma growing in nude mice.
International journal of radiation biology 2003;79(7):479-86.
2003: Cherry T Thomas; Patrick T Bradshaw; Bradley Pollock; James E Montie; Jeremy Taylor; Howard D Thames; Patrick W McLaughlin; David A Debiose; David H Hussey; Richard L Wahl
Indium-111-capromab pendetide radioimmunoscintigraphy and prognosis for durable biochemical response to salvage radiation therapy in men after failed prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(9):1715-21.
2003: Christopher H Crane; John M Skibber; Barry W Feig; Jean-Nicolas Vauthey; Howard D Thames; Steven A Curley; Miguel A Rodriguez-Bigas; Robert A Wolff; Lee M Ellis; Marc E Delclos; Edward H Lin; Nora Janjan
Response to preoperative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low rectal carcinoma.
Cancer 2003;97(2):517-24.
2002: Patricia J Eifel; Anuja Jhingran; Diane C Bodurka; Charles Levenback; Howard D Thames
Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(17):3651-7.
2002: Howard D Thames; Cordula Petersen; Sven Petersen; Carsten Nieder; Michael Baumann
Immunohistochemically detected p53 mutations in epithelial tumors and results of treatment with chemotherapy and radiotherapy. A treatment-specific overview of the clinical data.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2002;178(8):411-21.
2002: Thomas Buchholz; Angela Katz; Eric A Strom; Marsha D McNeese; George H Perkins; Gabriel N Hortobagyi; Howard D Thames; Henry M Kuerer; S Eva Singletary; Aysegul A Sahin; Kelly K Hunt; Aman U Buzdar; Vicente Valero; Nour Sneige; Susan L Tucker
Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy.
International journal of radiation oncology, biology, physics 2002;53(4):880-8.
2002: David J Brenner; Alvaro A Martinez; Gregory Edmundson; Christina Mitchell; Howard D Thames; Elwood P Armour
Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue.
International journal of radiation oncology, biology, physics 2002;52(1):6-13.
2001: Cordula Petersen; Daniel Zips; Mechthild Krause; K Schöne; Wolfgang Eicheler; Cordelia Hoinkis; Howard D Thames; Michael Baumann
Repopulation of FaDu human squamous cell carcinoma during fractionated radiotherapy correlates with reoxygenation.
International journal of radiation oncology, biology, physics 2001;51(2):483-93.
2001: Angela Katz; Thomas Buchholz; Howard D Thames; C D Smith; Marsha D McNeese; Richard Theriault; S Eva Singletary; Eric A Strom
Recursive partitioning analysis of locoregional recurrence patterns following mastectomy: implications for adjuvant irradiation.
International journal of radiation oncology, biology, physics 2001;50(2):397-403.
2001: Susan C Evans; D C Mack; Kathryn A Mason; Howard D Thames
The proliferative response of mouse jejunal crypt cells to radiation-induced cell depletion is not mediated exclusively by transforming growth factor alpha.
Radiation research 2001;155(6):866-9.
2000: Laura M Freedman; Thomas Buchholz; Howard D Thames; Eric A Strom; Marsha D McNeese; Gabriel N Hortobagyi; S Eva Singletary; KM Heaton; Kelly K Hunt
Local-regional control in breast cancer patients with a possible genetic predisposition.
International journal of radiation oncology, biology, physics 2000;48(4):951-7.
2000: Angela Katz; Eric A Strom; Thomas Buchholz; Howard D Thames; C D Smith; Anuja Jhingran; Gabriel N Hortobagyi; Aman U Buzdar; Richard Theriault; S Eva Singletary; Marsha D McNeese
Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(15):2817-27.
1999: Howard D Thames; Thomas Buchholz; C D Smith
Frequency of first metastatic events in breast cancer: implications for sequencing of systemic and local-regional treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(9):2649-58.
1999: Howard D Thames
[Multivariate analysis--do we understand what we are doing?].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1999;175 Suppl 1():8-9.
1998: Arnout C Ruifrok; Michael M Weil; Kathryn A Mason; Howard D Thames
Induction of transforming growth factor alpha in irradiated mouse jejunum.
International journal of radiation oncology, biology, physics 1998;42(5):1137-46.
1998: Arnout C Ruifrok; Michael M Weil; Howard D Thames; Kathryn A Mason
Diurnal variations in the expression of radiation-induced apoptosis.
Radiation research 1998;149(4):360-5.
1998: Horst Alheit; Michael Baumann; Howard D Thames; Peter Geyer; R Kumpf; Thomas Herrmann
Fractionation effect on radiation-induced growth retardation of tibia in rabbits and rats.
Acta oncologica (Stockholm, Sweden) 1998;37(2):151-8.
1998: Howard D Thames; K. Kian Ang
Altered fractionation: radiobiological principles, clinical results, and potential for dose escalation.
Cancer treatment and research 1998;93():101-28.
1997: Howard D Thames; Arnout C Ruifrok; Kathryn A Mason
The effect of proliferative status and clonogen content on the response of mouse jejunal crypts to split-dose irradiation.
Radiation research 1997;147(2):172-8.
1997: Arnout C Ruifrok; Kathryn A Mason; Guillermina Lozano; Howard D Thames
Spatial and temporal patterns of expression of epidermal growth factor, transforming growth factor alpha and transforming growth factor beta 1-3 and their receptors in mouse jejunum after radiation treatment.
Radiation research 1997;147(1):1-12.
1996: Bernard Dubray; Howard D Thames
The clinical significance of ratios of radiobiological parameters.
International journal of radiation oncology, biology, physics 1996;35(5):1099-111.
1996: Howard D Thames; Arnout C Ruifrok; Luka Milas; Nancy Hunter; Kathryn A Mason; Nicholas H A Terry; R A White
Accelerated repopulation during fractionated irradiation of a murine ovarian carcinoma: downregulation of apoptosis as a possible mechanism.
International journal of radiation oncology, biology, physics 1996;35(5):951-62.
1996: Arnout C Ruifrok; Kathryn A Mason; Howard D Thames
Changes in clonogen number and radiation sensitivity in mouse jejunal crypts after treatment with dimethylsulfoxide and retinoic acid.
Radiation research 1996;145(6):740-5.
1996: S M Bentzen; Arnout C Ruifrok; Howard D Thames
Repair capacity and kinetics for human mucosa and epithelial tumors in the head and neck: clinical data on the effect of changing the time interval between multiple fractions per day in radiotherapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1996;38(2):89-101.
1995: Bernard Dubray; Michel Henry-Amar; J H Meerwaldt; Evert M Noordijk; D O Dixon; Jean-Marc Cosset; Howard D Thames
Radiation-induced lung damage after thoracic irradiation for Hodgkin's disease: the role of fractionation.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1995;36(3):211-7.
1995: L Clifton Stephens; M E Robbins; D A Johnston; Howard D Thames; Roger E Price; LJ Peters; K. Kian Ang
Radiation nephropathy in the rhesus monkey: morphometric analysis of glomerular and tubular alterations.
International journal of radiation oncology, biology, physics 1995;31(4):865-73.
1995: E van Rongen; Elizabeth L Travis; Howard D Thames
Repair rate in mouse lung after clinically relevant radiation doses per fraction.
Radiation research 1995;141(1):74-8.
1994: Bernard Dubray; Howard D Thames
Chronic radiation damage in the rat rectum: an analysis of the influences of fractionation, time and volume.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1994;33(1):41-7.
1994: Arnout C Ruifrok; Kathryn A Mason; Nancy Hunter; Howard D Thames
Changes in the radiation sensitivity of mouse skin during fractionated and prolonged treatments.
Radiation research 1994;139(3):334-43.
1994: Luka Milas; T Nakayama; Nancy Hunter; S Jones; T M Lin; S Yamada; Howard D Thames; L Peters
Dynamics of tumor cell clonogen repopulation in a murine sarcoma treated with cyclophosphamide.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1994;30(3):247-53.
1994: Kathryn A Mason; Howard D Thames; T G Ochran; Arnout C Ruifrok; Nora Janjan
Comparison of continuous and pulsed low dose rate brachytherapy: biological equivalence in vivo.
International journal of radiation oncology, biology, physics 1994;28(3):667-71.
1993: E van Rongen; Howard D Thames; Elizabeth L Travis
Recovery from radiation damage in mouse lung: interpretation in terms of two rates of repair.
Radiation research 1993;133(2):225-33.
1993: V Hug; A Polyzos; S Tucker; Howard D Thames
The clonogenic growth of advanced breast tumour lesions adds no value to that of established clinical prognosticators for survival.
British journal of cancer 1993;67(2):222-5.
1993: Bernard Dubray; J P Bataini; J Bernier; Howard D Thames; C Lave; Bernard Asselain; C Jaulerry; F Brunin; Dominique Pontvert
Is reseeding from the primary a plausible cause of node failure?
International journal of radiation oncology, biology, physics 1993;25(1):9-15.
1992: K. Kian Ang; G L Jiang; R Guttenberger; Howard D Thames; L Clifton Stephens; C D Smith; Y Feng
Impact of spinal cord repair kinetics on the practice of altered fractionation schedules.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1992;25(4):287-94.
1992: Bernard Dubray; J J Mazeron; J M Simon; Howard D Thames; C Le Péchoux; Elie Calitchi; Yves Otmezguine; Jean-Paul Le Bourgeois; B Pierquin
Time factors in breast carcinoma: influence of delay between external irradiation and brachytherapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1992;25(4):267-72.
1992: Bernard Dubray; Théo Girinski; Howard D Thames; Aldo Becciolini; S Porciani; C Hennequin; G Socié; M Bonnay; Jean-Marc Cosset
Post-irradiation hyperamylasemia as a biological dosimeter.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1992;24(1):21-6.
1992: Howard D Thames; Timothy Schultheiss; J H Hendry; Susan L Tucker; Bernard Dubray; W A Brock
Can modest escalations of dose be detected as increased tumor control?
International journal of radiation oncology, biology, physics 1992;22(2):241-6.
1992: Susan L Tucker; I Turesson; Howard D Thames
Evidence for individual differences in the radiosensitivity of human skin.
European journal of cancer (Oxford, England : 1990) 1992;28A(11):1783-91.
1991: Luka Milas; S Yamada; Nancy Hunter; R Guttenberger; Howard D Thames
Changes in TCD50 as a measure of clonogen doubling time in irradiated and unirradiated tumors.
International journal of radiation oncology, biology, physics 1991;21(5):1195-202.
1991: Susan L Tucker; Howard D Thames; B W Brown; Kathryn A Mason; Nancy Hunter; H Rodney Withers
Direct analyses of in vivo colony survival after single and fractionated doses of radiation.
International journal of radiation biology 1991;59(3):777-95.
1990: Susan L Tucker; Howard D Thames; Jeremy Taylor
How well is the probability of tumor cure after fractionated irradiation described by Poisson statistics?
Radiation research 1990;124(3):273-82.
1990: Howard D Thames; S M Bentzen; I Turesson; M Overgaard; W Van den Bogaert
Time-dose factors in radiotherapy: a review of the human data.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1990;19(3):219-35.
1989: S M Bentzen; J Overgaard; Howard D Thames; M Overgaard; P Vejby Hansen; H von der Maase; J Meder
Clinical radiobiology of malignant melanoma.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1989;16(3):169-82.
1989: Howard D Thames; S M Bentzen; I Turesson; M Overgaard; W van den Bogaert
Fractionation parameters for human tissues and tumors.
International journal of radiation biology 1989;56(5):701-10.
1989: G L Jiang; K. Kian Ang; Howard D Thames; C S Wong; C D Wendt
Response of plateau-phase C3H 10T1/2 cells to radiation and concurrent administration of bleomycin.
Radiation research 1989;120(2):306-12.
1989: S M Bentzen; M Overgaard; Howard D Thames
Fractionation sensitivity of a functional endpoint: impaired shoulder movement after post-mastectomy radiotherapy.
International journal of radiation oncology, biology, physics 1989;17(3):531-7.
1989: S M Bentzen; Howard D Thames; M Overgaard
Latent-time estimation for late cutaneous and subcutaneous radiation reactions in a single-follow-up clinical study.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1989;15(3):267-74.
1989: Susan L Tucker; Howard D Thames
The effect of patient-to-patient variability on the accuracy of predictive assays of tumor response to radiotherapy: a theoretical evaluation.
International journal of radiation oncology, biology, physics 1989;17(1):145-57.
1989: Howard D Thames; J H Hendry; J V Moore; K. Kian Ang; Elizabeth L Travis
The high steepness of dose-response curves for late-responding normal tissues.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1989;15(1):49-53.
1989: Howard D Thames
Repair kinetics in tissues: alternative models.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1989;14(4):321-7.
1989: V Hug; Howard D Thames; S Bentzen
Predictors of hormone response for patients with ER-unknown breast tumours.
British journal of cancer 1989;59(3):421-5.
1989: S M Bentzen; Howard D Thames; Elizabeth L Travis; K. Kian Ang; E Van der Schueren; L Dewit; D O Dixon
Direct estimation of latent time for radiation injury in late-responding normal tissues: gut, lung, and spinal cord.
International journal of radiation biology 1989;55(1):27-43.
1988: Howard D Thames
A new model of proliferative response to fractionated irradiation.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1988;13(4):311-3.
1988: K. Kian Ang; Howard D Thames; S D Jones; G L Jiang; Luka Milas; LJ Peters
Proliferation kinetics of a murine fibrosarcoma during fractionated irradiation.
Radiation research 1988;116(2):327-36.
1988: L Vanuytsel; Y Feng; Willy Landuyt; Howard D Thames; E van der Schueren
Effect of continuous infusion of bleomycin on the time for completion of repair of sublethal radiation damage in mouse lip mucosa during fractionated irradiation.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1988;12(4):333-7.
1988: Howard D Thames; K. Kian Ang; F A Stewart; E van der Schueren
Does incomplete repair explain the apparent failure of the basic LQ model to predict spinal cord and kidney responses to low doses per fraction?
International journal of radiation biology 1988;54(1):13-9.
1988: V Hug; Howard D Thames; A Polyzos; D Johnston
Chemoresistance is not a cause of the apparent failure of adjuvant chemotherapy in postmenopausal women.
European journal of cancer & clinical oncology 1988;24(4):713-8.